Consideration of pathogenesis of rheumatoid arthritis as collagen autoimmunity.
D000974:Antibodies, Antinuclear / Q000032:analysis; D000918:Antibody Specificity; D000941:Antigens; D001172:Arthritis, Rheumatoid / Q000209:etiology* / Q000276:immunology; D001323:Autoantibodies / Q000032:analysis*; D001327:Autoimmune Diseases / Q000276:immunology*; D001842:Bone and Bones / Q000201:enzymology; D003013:Clostridium / Q000201:enzymology; D003094:Collagen; D005258:Felty Syndrome / Q000276:immunology; D006073:Gout / Q000276:immunology; D006367:HeLa Cells / Q000201:enzymology; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D006969:Hypersensitivity, Immediate / Q000276:immunology; D007249:Inflammation / Q000201:enzymology; D007962:Leukocytes / Q000201:enzymology; D008180:Lupus Erythematosus, Systemic / Q000276:immunology; D010434:Pepsin A / Q000494:pharmacology; D012859:Sjogren's Syndrome / Q000276:immunology; D012867:Skin / Q000201:enzymology; D012995:Solubility; D013045:Species Specificity; D013582:Synovial Fluid / Q000201:enzymology
D000974:Antibodies, Antinuclear; D000941:Antigens; D001323:Autoantibodies; D003094:Collagen; D010434:Pepsin A